Following the discussion, the Executive Committee decided:
- To approve the transition strategy for phasing out use of CFCs in the manufacturing of metered-dose inhalers (MDIs) in Bangladesh at a funding level of US $70,000 plus agency support costs of US $9,100 for UNEP;
- To approve the project for the phase-out of CFC consumption in the manufacture of metered-dose inhalers in Bangladesh at the amount of US $2,776,778 plus agency support costs of US $208,258 for UNDP, having taken into account the deduction of US $128,500 to eliminate double-counting of funds provided under the national phase‑out plan (NPP) and the MDI conversion project, and on the understanding that no further funding would be provided for CFC-MDI conversion in Bangladesh; and
- To request UNDP to obtain from the enterprises receiving funding under the MDI conversion project letters stating their commitment to provide counterpart funding, and their commitment to stop production of CFC-MDI products converted to non-CFC technology immediately upon completion of the conversion project, with the understanding that the requirement to provide letters of commitment would be extended to all future MDI conversion projects proposed by other Article 5 countries.